SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 57 filers reported holding SIO GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,786 | -77.4% | 15,600 | -85.2% | 0.00% | -100.0% |
| Q3 2022 | $30,000 | -46.4% | 105,400 | -32.2% | 0.00% | 0.0% |
| Q2 2022 | $56,000 | -65.9% | 155,400 | -36.5% | 0.00% | -66.7% |
| Q1 2022 | $164,000 | -63.1% | 244,900 | -29.0% | 0.00% | -62.5% |
| Q4 2021 | $445,000 | -50.4% | 344,900 | -16.7% | 0.01% | -52.9% |
| Q3 2021 | $898,000 | +10.3% | 413,900 | +38.8% | 0.02% | +13.3% |
| Q2 2021 | $814,000 | -2.0% | 298,300 | -6.3% | 0.02% | -6.2% |
| Q1 2021 | $831,000 | – | 318,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
| Prosight Management, LP | 670,300 | $449,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
| Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
| Clearline Capital LP | 392,691 | $263,000 | 0.03% |
| APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
| Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
| NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |